Year: 2020

Oxford University breakthrough on global COVID-19 vaccine

Oxford, UK - Vaccitech’s scientific founders at University of Oxford announce positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil. Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is...

Apprentice Laboratory Technician

Vaccitech is looking to employ an Apprentice Laboratory Technician to provide technical support for the day-to-day smooth operation of our vaccine research laboratory, as well completing training to become a fully qualified laboratory technician. This position will...

Clinical Study Manager

Due to exciting expansion across the company, with offices in the UK (headquarters), USA, Italy and Australia, Vaccitech is now recruiting for a Clinical Study Manager, which is an office-based role in the UK on a full time basis (37.5 hours per week). Please see the...

Vaccitech expands management team with hires including CMO and CFO

Oxford, UK – Vaccitech Ltd, a clinical-stage biopharmaceutical company developing T cell vaccines and immunotherapies designed to treat and prevent infectious disease and cancer, today announces the appointment of three new senior leaders across its clinical,...